Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its supply have become key issues for patients and healthcare providers. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant challenge to many. Nego